These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 15305383)

  • 1. Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer.
    Ekici S; Cerwinka WH; Duncan R; Gomez P; Civantos F; Soloway MS; Lokeshwar VB
    Int J Cancer; 2004 Oct; 112(1):121-9. PubMed ID: 15305383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer.
    Posey JT; Soloway MS; Ekici S; Sofer M; Civantos F; Duncan RC; Lokeshwar VB
    Cancer Res; 2003 May; 63(10):2638-44. PubMed ID: 12750291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.
    Gettman MT; Pacelli A; Slezak J; Bergstralh EJ; Blute M; Zincke H; Bostwick DG
    Urology; 1999 Sep; 54(3):479-85. PubMed ID: 10475358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 (COX-2) expression is an independent predictor of prostate cancer recurrence.
    Cohen BL; Gomez P; Omori Y; Duncan RC; Civantos F; Soloway MS; Lokeshwar VB; Lokeshwar BL
    Int J Cancer; 2006 Sep; 119(5):1082-7. PubMed ID: 16557596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer.
    Kramer MW; Golshani R; Merseburger AS; Knapp J; Garcia A; Hennenlotter J; Duncan RC; Soloway MS; Jorda M; Kuczyk MA; Stenzl A; Lokeshwar VB
    Eur Urol; 2010 Jan; 57(1):86-93. PubMed ID: 19345473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic acid and HYAL-1 in prostate biopsy specimens: predictors of biochemical recurrence.
    Gomez CS; Gomez P; Knapp J; Jorda M; Soloway MS; Lokeshwar VB
    J Urol; 2009 Oct; 182(4):1350-6. PubMed ID: 19683287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors.
    Franzmann EJ; Schroeder GL; Goodwin WJ; Weed DT; Fisher P; Lokeshwar VB
    Int J Cancer; 2003 Sep; 106(3):438-45. PubMed ID: 12845686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.
    Zellweger T; Günther S; Zlobec I; Savic S; Sauter G; Moch H; Mattarelli G; Eichenberger T; Curschellas E; Rüfenacht H; Bachmann A; Gasser TC; Mihatsch MJ; Bubendorf L
    Int J Cancer; 2009 May; 124(9):2116-23. PubMed ID: 19117060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of prognosis in patients with prostate cancer treated with radical prostatectomy: prognostic value of CD44v6 score.
    Ekici S; Ayhan A; Kendi S; Ozen H
    J Urol; 2002 May; 167(5):2037-41. PubMed ID: 11956433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
    Zhou M; Hayasaka S; Taylor JM; Shah R; Proverbs-Singh T; Manley S; Rubin MA
    J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens.
    Marks RA; Koch MO; Lopez-Beltran A; Montironi R; Juliar BE; Cheng L
    Hum Pathol; 2007 Aug; 38(8):1207-11. PubMed ID: 17490720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent prognostic importance of microvessel density in clinically localized prostate cancer.
    Halvorsen OJ; Haukaas S; Høisaeter PA; Akslen LA
    Anticancer Res; 2000; 20(5C):3791-9. PubMed ID: 11268456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
    Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH
    Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profile of CD44s, CD44v6, and CD44v10 in localized prostate cancer: effect on prognostic outcomes following radical prostatectomy.
    Tei H; Miyake H; Harada K; Fujisawa M
    Urol Oncol; 2014 Jul; 32(5):694-700. PubMed ID: 24468288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong Stromal Hyaluronan Expression Is Associated with PSA Recurrence in Local Prostate Cancer.
    Aaltomaa S; Lipponen P; Tammi R; Tammi M; Viitanen J; Kankkunen JP; Kosma VM
    Urol Int; 2002; 69(4):266-72. PubMed ID: 12444281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual estimation of tumour extent is not an independent predictor of prostate specific antigen recurrence.
    Jones TD; Koch MO; Lin H; Cheng L
    BJU Int; 2005 Dec; 96(9):1253-7. PubMed ID: 16287440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Akt Activation Correlates with Snail Expression and Potentially Determines the Recurrence of Prostate Cancer in Patients at Stage T2 after a Radical Prostatectomy.
    Chen WY; Hua KT; Lee WJ; Lin YW; Liu YN; Chen CL; Wen YC; Chien MH
    Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27455254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosis.
    Kramer MW; Escudero DO; Lokeshwar SD; Golshani R; Ekwenna OO; Acosta K; Merseburger AS; Soloway M; Lokeshwar VB
    Cancer; 2011 Mar; 117(6):1197-209. PubMed ID: 20960509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.